3Zhang LX,Tu DH,He GX, et al. Risk of tuberculosis infection and tuberculosis meningitis after discontinuation of BCG in Beijing[J]. Am J Respir Crit Care Med, 2000,162:1314～1317
4IUAT Commitee on Prophlaxis. Efficacy of various duration of isoniazid prevetive therapy to tuberculosis:five years of follow up in the IUAT trial[M]. Bull WHO, 1982,60:555～64
5Hong Kong Chest Service/Tuberculosis Research Centre, British Medical Research Council. A double-blind placebo-controlled Clinical of three anti tuberculosis chemoprophylaxia regimens in patients with silicosis in Hong Kong[J]. Am Respir Dis, 1992,145:36～41
6Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommen dations Against the Use of Rifampin and Pyrazinamide for Treatment of Letent Tuberculosis Infection-United States 2003[J]. MMWR 2003,52:735～739
7Watkins RE, Brennan R, Plant AT. Tuberculin reactivity and the risk of tuberculosis a review[J]. Int J Tuberc Dis, 2000,4:895～903
8Watkins RE, Brennan R, Plant AJ. Tuberculin reactivity and the risk of tuberculosis: a review [ J ]. INT J TUBERC LUNG DIS, 2000,4(10) :859-903.
9American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children [ J ]. Am J Respir Crit Care Med, 1994,149 : 1359 - 1374.
